Related Articles
In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R
Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells.
The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice
The prolactin receptor mediates HOXA1-stimulated oncogenicity in mammary carcinoma cells
Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/neu transgenic mice